160 related articles for article (PubMed ID: 16466920)
1. New derivatives of silybin and 2,3-dehydrosilybin and their cytotoxic and P-glycoprotein modulatory activity.
Dzubák P; Hajdúch M; Gazák R; Svobodová A; Psotová J; Walterová D; Sedmera P; Kren V
Bioorg Med Chem; 2006 Jun; 14(11):3793-810. PubMed ID: 16466920
[TBL] [Abstract][Full Text] [Related]
2. Silybin and dehydrosilybin inhibit cytochrome P450 1A1 catalytic activity: a study in human keratinocytes and human hepatoma cells.
Dvorák Z; Vrzal R; Ulrichová J
Cell Biol Toxicol; 2006 Mar; 22(2):81-90. PubMed ID: 16528449
[TBL] [Abstract][Full Text] [Related]
3. Increased anti-P-glycoprotein activity of baicalein by alkylation on the A ring.
Lee Y; Yeo H; Liu SH; Jiang Z; Savizky RM; Austin DJ; Cheng YC
J Med Chem; 2004 Oct; 47(22):5555-66. PubMed ID: 15481991
[TBL] [Abstract][Full Text] [Related]
4. Oxidised derivatives of silybin and their antiradical and antioxidant activity.
Gazák R; Svobodová A; Psotová J; Sedmera P; Prikrylová V; Walterová D; Kren V
Bioorg Med Chem; 2004 Nov; 12(21):5677-87. PubMed ID: 15465345
[TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationship of natural and synthetic coumarins inhibiting the multidrug transporter P-glycoprotein.
Raad I; Terreux R; Richomme P; Matera EL; Dumontet C; Raynaud J; Guilet D
Bioorg Med Chem; 2006 Oct; 14(20):6979-87. PubMed ID: 16824763
[TBL] [Abstract][Full Text] [Related]
6. New C-23 modified of silybin and 2,3-dehydrosilybin: synthesis and preliminary evaluation of antioxidant properties.
Zarrelli A; Sgambato A; Petito V; De Napoli L; Previtera L; Di Fabio G
Bioorg Med Chem Lett; 2011 Aug; 21(15):4389-92. PubMed ID: 21737270
[TBL] [Abstract][Full Text] [Related]
7. Reversal of p-glycoprotein-mediated multidrug resistance by macrocyclic bisbibenzyl derivatives in adriamycin-resistant human myelogenous leukemia (K562/A02) cells.
Li X; Sun B; Zhu CJ; Yuan HQ; Shi YQ; Gao J; Li SJ; Lou HX
Toxicol In Vitro; 2009 Feb; 23(1):29-36. PubMed ID: 18938236
[TBL] [Abstract][Full Text] [Related]
8. Effects of silymarin flavonolignans and synthetic silybin derivatives on estrogen and aryl hydrocarbon receptor activation.
Plísková M; Vondrácek J; Kren V; Gazák R; Sedmera P; Walterová D; Psotová J; Simánek V; Machala M
Toxicology; 2005 Nov; 215(1-2):80-9. PubMed ID: 16076518
[TBL] [Abstract][Full Text] [Related]
9. Small P-gp modulating molecules: SAR studies on tetrahydroisoquinoline derivatives.
Colabufo NA; Berardi F; Cantore M; Perrone MG; Contino M; Inglese C; Niso M; Perrone R; Azzariti A; Simone GM; Porcelli L; Paradiso A
Bioorg Med Chem; 2008 Jan; 16(1):362-73. PubMed ID: 17936633
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of anticancer effects of newly synthesized dihydropyridine derivatives in comparison to verapamil and doxorubicin on T47D parental and resistant cell lines in vitro.
Bazargan L; Fouladdel S; Shafiee A; Amini M; Ghaffari SM; Azizi E
Cell Biol Toxicol; 2008 Apr; 24(2):165-74. PubMed ID: 17805981
[TBL] [Abstract][Full Text] [Related]
11. 2,3-dehydrosilybin is a better DNA topoisomerase I inhibitor than its parental silybin.
Thongphasuk P; Stremmel W; Chamulitrat W
Chemotherapy; 2009; 55(1):42-8. PubMed ID: 19023201
[TBL] [Abstract][Full Text] [Related]
12. Transmembrane inhibitors of P-glycoprotein, an ABC transporter.
Tarasova NI; Seth R; Tarasov SG; Kosakowska-Cholody T; Hrycyna CA; Gottesman MM; Michejda CJ
J Med Chem; 2005 Jun; 48(11):3768-75. PubMed ID: 15916428
[TBL] [Abstract][Full Text] [Related]
13. Tumour-specific cytotoxicity and MDR-reversal activity of dihydropyridines.
Engi H; Sakagami H; Kawase M; Parecha A; Manvar D; Kothari H; Adlakha P; Shah A; Motohashi N; Ocsovszki I; Molnár J
In Vivo; 2006; 20(5):637-43. PubMed ID: 17091771
[TBL] [Abstract][Full Text] [Related]
14. Effects of 2,3-Dehydrosilybin and Its Galloyl Ester and Methyl Ether Derivatives on Human Umbilical Vein Endothelial Cells.
Karas D; Gažák R; Valentová K; Chambers CS; Pivodová V; Biedermann D; Křenková A; Oborná I; Kuzma M; Cvačka J; Ulrichová J; Křen V
J Nat Prod; 2016 Apr; 79(4):812-20. PubMed ID: 27015547
[TBL] [Abstract][Full Text] [Related]
15. Synergistic interaction between p-glycoprotein modulators and epirubicine on resistant cancer cells.
Duarte N; Járdánházy A; Molnár J; Hilgeroth A; Ferreira MJ
Bioorg Med Chem; 2008 Oct; 16(20):9323-30. PubMed ID: 18824363
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms of silybin and 2,3-dehydrosilybin antiradical activity--role of individual hydroxyl groups.
Gazák R; Sedmera P; Vrbacký M; Vostálová J; Drahota Z; Marhol P; Walterová D; Kren V
Free Radic Biol Med; 2009 Mar; 46(6):745-58. PubMed ID: 19138735
[TBL] [Abstract][Full Text] [Related]
17. New cytotoxic diterpenylnaphthohydroquinone derivatives obtained from a natural diterpenoid.
Miguel Del Corral JM; Castro MA; Lucena Rodri Guez M; Chamorro P; Cuevas C; San Feliciano A
Bioorg Med Chem; 2007 Sep; 15(17):5760-74. PubMed ID: 17583515
[TBL] [Abstract][Full Text] [Related]
18. Substituted tetrahydroisoquinoline compound B3 inhibited P-glycoprotein-mediated multidrug resistance in-vitro and in-vivo.
Fang W; Li Y; Cai Y; Kang K; Yan F; Liu G; Huang W
J Pharm Pharmacol; 2007 Dec; 59(12):1649-55. PubMed ID: 18053326
[TBL] [Abstract][Full Text] [Related]
19. Prolongation of pentoxifylline aliphatic side chain positively affects the reversal of P-glycoprotein-mediated multidrug resistance in L1210/VCR line cells.
Docolomanský P; Fialová I; Barancík M; Rybár A; Breier A
Gen Physiol Biophys; 2005 Dec; 24(4):461-6. PubMed ID: 16474189
[TBL] [Abstract][Full Text] [Related]
20. Effect of Stemona curtisii root extract on P-glycoprotein and MRP-1 function in multidrug-resistant cancer cells.
Limtrakul P; Siwanon S; Yodkeeree S; Duangrat C
Phytomedicine; 2007 Jun; 14(6):381-9. PubMed ID: 17467965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
